Detected ·

MyoPax

——

Berlin biotech MyoPax, a Charité/Max Delbrück Center spin-off developing a muscle stem cell + CRISPR gene-repair therapy platform, has received funding from IBB Ventures' new B# Plus fund, complementing EIC Accelerator support.

Website
myopax.com
Amount
—
Stage
—
Event
Funding round
Detected
2026-10-13 08:02:17 UTC
Signal ID
1c415faa-21ed-4c1b-8120-17f8ba657040

As the API returns it

{
  "id": "1c415faa-21ed-4c1b-8120-17f8ba657040",
  "created_at": "2026-10-13T08:02:17.214274Z",
  "company_name": "MyoPax",
  "company_website_url": "myopax.com",
  "company_linkedin_url": "https://www.linkedin.com/company/86304529",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Berlin biotech MyoPax, a Charité/Max Delbrück Center spin-off developing a muscle stem cell + CRISPR gene-repair therapy platform, has received funding from IBB Ventures' new B# Plus fund, complementing EIC Accelerator support.*"
}

Latest rounds